Global cholera vaccines market is anticipated to grow significantly during forecast period due to rising government initiatives in immunization program and growing incidence of cholera particularly in developing countries in Asia and Africa would drive the growth of cholera vaccines market globally.

The report titled “Cholera Vaccines Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall Cholera Vaccines market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on type of product and different geographical regions. Geographically, the global cholera vaccines market is studied for the following regional markets:   

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global cholera vaccines market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global cholera vaccines market. This report concludes with company profiles section that highlights major information about the key players engaged in global cholera vaccines market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.     

Thus, the research study provides a holistic view of the global cholera vaccines market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on product type, the global cholera vaccines market is segmented as follows:  

• Dukoral
• Shanchol
• Vaxchora
• Others

Cholera is an infectious disease that causes severe watery diarrhea, which can lead to even death if untreated. The burden of cholera remains high globally, particularly in resource poor countries in Asia and Africa. According to World Health Organization (WHO), there are roughly 1.4 to 4.0 million cholera cases, and 21,000 to 143,000 deaths worldwide each year due to cholera. There are different types of vaccines available in market such as killed whole cell vaccine with cholera toxin B subunit, vietnamese killed whole cell-only vaccine, modified killed whole cell-only vaccines, and live oral vaccines such as CVD 103-HgR. In the base year 2016, Dukoral was major revenue generating segment as it is prequalified by World Health Organization (WHO) and has been licensed in more than 60 countries also it preferably used in treatment of diarrhea caused by Vibrio cholera and heat-labile toxin producing enterotoxigenic Escherichia coli (ETEC) these are the prime factors that driving the growth of Dukoral market globally. It is estimated that recently approved (June, 2016) Vaxchora will show significant growth during forecast period due to its safety, availability and effectiveness would expected to drive the market growth during forecast period. Vaxchora is the only vaccine available in the United States for protection against cholera and the only single dose vaccine for cholera currently licensed anywhere in the world.

For the purpose of this study, the global cholera vaccines market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

According to World Health Organization (WHO), cholera represents an estimated burden of 1.4 to 4.0 million cases, and 21,000 to 143,000 deaths per year worldwide. For the purpose of this study, the global cholera market is regionally categorized as North America, Europe, Asia Pacific, LATAM and MEA; among the considered regional markets North America is expected to dominate the cholera market during forecast period due to higher healthcare awareness among general population, government initiatives in treatment and awareness program, higher cost of vaccines and presence of key manufacturer would drive the market growth in North America, recently approved vaxchora would primarily assist market growth in North America.  Centers for Disease Control and Prevention (CDC) recommendation for travelers to cholera-affected regions would fuel the market growth in United States. On the other hand, Asia Pacific is currently dominating the Cholera vaccines market due to increasing awareness of immunization, higher number of targeted population and government initiatives in awareness program are primarily driving the market growth in Asia Pacific.